Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $3.54 billion. The enterprise value is $2.93 billion.

Market Cap	3.54B
Enterprise Value	2.93B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

APGE has 65.51 million shares outstanding. The number of shares has increased by 17.27% in one year.

Current Share Class	52.03M
Shares Outstanding	65.51M
Shares Change (YoY)	+17.27%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	2.00%
Owned by Institutions (%)	77.64%
Float	37.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.10
P/TBV Ratio	5.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.36, with a Debt / Equity ratio of 0.02.

Current Ratio	16.36
Quick Ratio	16.15
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -34.12% and return on invested capital (ROIC) is -24.04%.

Return on Equity (ROE)	-34.12%
Return on Assets (ROA)	-23.21%
Return on Invested Capital (ROIC)	-24.04%
Return on Capital Employed (ROCE)	-43.25%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	196
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, APGE has paid $173,000 in taxes.

Income Tax	173,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.22% in the last 52 weeks. The beta is 1.44, so APGE's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	-5.22%
50-Day Moving Average	38.76
200-Day Moving Average	38.79
Relative Strength Index (RSI)	83.62
Average Volume (20 Days)	815,249

Short Selling Information

The latest short interest is 9.45 million, so 14.42% of the outstanding shares have been sold short.

Short Interest	9.45M
Short Previous Month	8.95M
Short % of Shares Out	14.42%
Short % of Float	25.05%
Short Ratio (days to cover)	16.76

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.83M
Pretax Income	-237.50M
Net Income	-237.67M
EBITDA	-270.10M
EBIT	-270.83M
Earnings Per Share (EPS)	-$4.12

Balance Sheet

The company has $505.42 million in cash and $10.85 million in debt, giving a net cash position of $610.34 million or $9.32 per share.

Cash & Cash Equivalents	505.42M
Total Debt	10.85M
Net Cash	610.34M
Net Cash Per Share	$9.32
Equity (Book Value)	619.40M
Book Value Per Share	10.58
Working Capital	484.57M

Cash Flow

In the last 12 months, operating cash flow was -$220.74 million and capital expenditures -$5.84 million, giving a free cash flow of -$226.58 million.

Operating Cash Flow	-220.74M
Capital Expenditures	-5.84M
Free Cash Flow	-226.58M
FCF Per Share	-$3.46

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.27%
Shareholder Yield	-17.27%
Earnings Yield	-6.72%
FCF Yield	-6.41%

Analyst Forecast

The average price target for APGE is $93.14, which is 72.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$93.14
Price Target Difference	72.58%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	13.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1